Aetna CEO expects some ACA benefits to stay: Dealbook conference
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Mark Bertolini, Chairman and CEO of Aetna, participates in a panel discussion at the 2015 Fortune Global Forum in San Francisco, California November 3, 2015. REUTERS/Elijah Nouvelage/File Photo
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
NEW YORK (Reuters) - Aetna Inc Chief Executive Officer Mark Bertolini said he expected some benefits of President Barack Obama's national healthcare reform law will stick under President-elect Donald Trump, like allowing young adults to stay on their family's health insurance.
Bertolini, speaking at the New York Times Dealbook conference, said he expects the expansion of Medicaid to more people will continue but with new mechanisms for federal financing. He also sees some sort of subsidies for individual insurance remaining.
Trump has promised to repeal the Affordable Care Act, known as Obamacare, which passed in 2010 and was Obama's signature domestic policy.
(Reporting by Caroline Humer; Editing by Chizu Nomiyama)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Maintains Neutral View on Smith & Wesson (SWHC) as Outlook Moderates Post Election
- Netanyahu says will discuss with Trump 'bad' Iran nuclear deal
- Women, children leave Islamic State holdout in Sirte: Libyan forces
Create E-mail Alert Related CategoriesReuters
Related EntitiesDonald J. Trump, Barack Obama
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!